{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:25:06Z","timestamp":1762507506268},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.neurol.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T20:52:41Z","timestamp":1538081561000},"page":"261-268","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inflammatory demyelinating diseases of the central nervous system in Niger"],"prefix":"10.1016","volume":"175","author":[{"given":"H.","family":"Assadeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Toudou Daouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9.","family":"Adehossi Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Mamadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hassane Djibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Douma Maiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neurol.2018.05.003_bib0175","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/jnnp.57.9.1064","article-title":"Multiple sclerosis in black South Africans and Zimbabweans","volume":"57","author":"Dean","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.neurol.2018.05.003_bib0180","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1177\/1352458509345913","article-title":"Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome","volume":"15","author":"Idris","year":"2009","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.neurol.2018.05.003_bib0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4314\/eamj.v78i2.9096","article-title":"Emerging picture of multiple sclerosis in Kenya","volume":"78","author":"Kioy","year":"2001","journal-title":"East Afr Med J"},{"issue":"10, Suppl","key":"10.1016\/j.neurol.2018.05.003_bib0190","article-title":"Unveiling multiple sclerosis in Nigeria: the conundrum of diagnosis and access to disease modifying therapies","volume":"82","author":"Okubadejo","year":"2014","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2018.05.003_bib0195","article-title":"La neuromy\u00e9lite optique (NMO) au Mali: quelle r\u00e9alit\u00e9?","volume":"172","author":"Maiga","year":"2016","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2018.05.003_bib0200","first-page":"3","article-title":"Devic disease in Senegal, a west african country: about five cases","volume":"2","author":"Dadah Samy","year":"2017","journal-title":"ARC J Neurosci"},{"key":"10.1016\/j.neurol.2018.05.003_bib0205","article-title":"First cases of multiple sclerosis in Niger","author":"Assadeck","year":"2018","journal-title":"Bull Soc Pathol Exot"},{"issue":"4","key":"10.1016\/j.neurol.2018.05.003_bib0210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0022-510X(71)90110-9","article-title":"The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria","volume":"12","author":"Osuntokun","year":"1971","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.neurol.2018.05.003_bib0215","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jnnp.70.4.500","article-title":"Demyelinating disorder of the central nervous system occurring in black South Africans","volume":"70","author":"Modi","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2018.05.003_bib0220","first-page":"249","article-title":"Case report and speculation","volume":"60","author":"Cosnett","year":"1981","journal-title":"S Afr Med J"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2018.05.003_bib0225","article-title":"Caract\u00e9ristiques \u00e9pid\u00e9mio-cliniques et \u00e9tiologiques des my\u00e9lopathies dans le service de neurologie du CHU de Cocody d\u2019Abidjan (C\u00f4te d\u2019Ivoire)","volume":"174","author":"Mamadou","year":"2018","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2018.05.003_bib0230","first-page":"18","article-title":"First documented case of Devic's neuromyelitis optica in Niger","volume":"1","author":"Assadeck","year":"2017","journal-title":"Jaccr Africa"},{"issue":"2","key":"10.1016\/j.neurol.2018.05.003_bib0235","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2018.05.003_bib0240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.05.003_bib0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-Gomez","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2018.05.003_bib0250","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2018.05.003_bib0255","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2018.05.003_bib0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2015.05.034","article-title":"Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: a review","volume":"355","author":"Pereira","year":"2015","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.neurol.2018.05.003_bib0265","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","article-title":"The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes","volume":"34","author":"Sellner","year":"2010","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.neurol.2018.05.003_bib0270","first-page":"146","article-title":"HLA-DRB1 typing in Caucasians patients with neuromyelitis optica","volume":"53","author":"Blanco","year":"2011","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2018.05.003_bib0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1352458510382810","article-title":"Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population","volume":"17","author":"Deschamps","year":"2011","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.neurol.2018.05.003_bib0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1352458509350741","article-title":"HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis","volume":"16","author":"Brum","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2018.05.003_bib0285","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.05.003_bib0290","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.0b013e31820a0a9f","article-title":"Association of UV radiation with multiple sclerosis prevalence and sex ratio in France","volume":"76","author":"Orton","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2018.05.003_bib0295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0317167100007587","article-title":"The relation of ultraviolet radiation and multiple sclerosis in Newfoundland","volume":"35","author":"Sloka","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neurol.2018.05.003_bib0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.expneurol.2013.08.002","article-title":"Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage","volume":"249","author":"Adzemovic","year":"2013","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2018.05.003_bib0305","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.neurol.2018.05.003_bib0310","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/jnnp-2014-309495","article-title":"Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females","volume":"86","author":"Pedrini","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2018.05.003_bib0315","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-2478(02)00025-1","article-title":"Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections","volume":"82","author":"Sewell","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.neurol.2018.05.003_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.015","article-title":"The role of microbiome in central nervous system disorders","volume":"38","author":"Wang","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.1016\/j.neurol.2018.05.003_bib0325","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.173.2.1224","article-title":"CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development","volume":"173","author":"McKee","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.neurol.2018.05.003_bib0330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.10788","article-title":"Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography","volume":"55","author":"Wallin","year":"2004","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2018.05.003_bib0335","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1191\/1352458503ms909oa","article-title":"Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium","volume":"9","author":"Weinstock-Guttman","year":"2003","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.neurol.2018.05.003_bib0340","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1177\/1352458507079274","article-title":"Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study","volume":"13","author":"Bhigjee","year":"2007","journal-title":"Mult Scler"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378718305794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378718305794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T10:07:19Z","timestamp":1555063639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378718305794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0035378718305794"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2018.05.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory demyelinating diseases of the central nervous system in Niger","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}